| 12/06/25 | GSK | 11:00:00 | 12 Jun 2025 | | GSK | Director/PDMR Shareholding | GSK plc | PRN |
| 25/05/22 | GSK | 15:41:00 | 25 May 2022 | | GSK | Director/PDMR Shareholding | GSK plc | PRN |
| 01/12/21 | GSK | 11:05:00 | 1 Dec 2021 | | GSK | Total Voting Rights | GSK plc | PRN |
| 20/09/13 | | 18:20:04 | 20 Sept 2013 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 19/09/13 | | 19:25:03 | 19 Sept 2013 | | | Relvar Ellipta CHMP Positive Opinion | GlaxoSmithKline PLC | RNS |
| 17/09/13 | | 18:19:03 | 17 Sept 2013 | | | Transaction in Own Shares | GlaxoSmithKline PLC | RNS |
| 16/09/13 | | 18:27:31 | 16 Sept 2013 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 16/09/13 | | 18:27:20 | 16 Sept 2013 | | | Transaction in Own Shares | GlaxoSmithKline PLC | RNS |
| 16/09/13 | | 11:00:01 | 16 Sept 2013 | | | dabrafenib/trametinib combo - FDA Priority Review | GlaxoSmithKline PLC | RNS |
| 13/09/13 | | 18:14:00 | 13 Sept 2013 | | | Transaction in Own Shares | GlaxoSmithKline PLC | RNS |
| 12/09/13 | | 18:20:23 | 12 Sept 2013 | | | Transaction in Own Shares | GlaxoSmithKline PLC | RNS |
| 11/09/13 | | 18:23:16 | 11 Sept 2013 | | | Transaction in Own Shares | GlaxoSmithKline PLC | RNS |
| 11/09/13 | | 16:46:58 | 11 Sept 2013 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 11/09/13 | | 16:44:09 | 11 Sept 2013 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 11/09/13 | | 08:00:04 | 11 Sept 2013 | | | FDA AdCom recommends Anoro Ellipta (UMEC/VI) | GlaxoSmithKline PLC | RNS |
| 09/09/13 | | 09:30:10 | 9 Sept 2013 | | | GSK to divest Lucozade and Ribena for £1.35bn | GlaxoSmithKline PLC | RNS |
| 05/09/13 | | 08:00:12 | 5 Sept 2013 | | | MAGE A-3 Phase III DERMA Study Results | GlaxoSmithKline PLC | RNS |
| 04/09/13 | | 12:50:14 | 4 Sept 2013 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 02/09/13 | | 18:22:37 | 2 Sept 2013 | | | Transaction in Own Shares | GlaxoSmithKline PLC | RNS |
| 02/09/13 | | 13:27:40 | 2 Sept 2013 | | | Total Voting Rights | GlaxoSmithKline PLC | RNS |
| 30/08/13 | | 18:18:18 | 30 Aug 2013 | | | Transaction in Own Shares | GlaxoSmithKline PLC | RNS |
| 29/08/13 | | 18:03:41 | 29 Aug 2013 | | | Transaction in Own Shares | GlaxoSmithKline PLC | RNS |
| 28/08/13 | | 18:08:18 | 28 Aug 2013 | | | Transaction in Own Shares | GlaxoSmithKline PLC | RNS |
| 28/08/13 | | 15:50:51 | 28 Aug 2013 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 28/08/13 | | 15:48:16 | 28 Aug 2013 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 27/08/13 | | 18:01:03 | 27 Aug 2013 | | | Transaction in Own Shares | GlaxoSmithKline PLC | RNS |
| 23/08/13 | | 17:50:27 | 23 Aug 2013 | | | Transaction in Own Shares | GlaxoSmithKline PLC | RNS |
| 22/08/13 | | 17:51:04 | 22 Aug 2013 | | | Transaction in Own Shares | GlaxoSmithKline PLC | RNS |
| 21/08/13 | | 17:40:29 | 21 Aug 2013 | | | Transaction in Own Shares | GlaxoSmithKline PLC | RNS |
| 20/08/13 | | 17:56:01 | 20 Aug 2013 | | | Transaction in Own Shares | GlaxoSmithKline PLC | RNS |
| 19/08/13 | | 16:58:18 | 19 Aug 2013 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 16/08/13 | | 17:50:46 | 16 Aug 2013 | | | Transaction in Own Shares | GlaxoSmithKline PLC | RNS |
| 15/08/13 | | 17:58:20 | 15 Aug 2013 | | | Transaction in Own Shares | GlaxoSmithKline PLC | RNS |
| 14/08/13 | | 17:55:04 | 14 Aug 2013 | | | Transaction in Own Shares | GlaxoSmithKline PLC | RNS |
| 13/08/13 | | 08:00:07 | 13 Aug 2013 | | | Tivicay® (dolutegravir) receives FDA approval | GlaxoSmithKline PLC | RNS |
| 12/08/13 | | 17:55:54 | 12 Aug 2013 | | | Transaction in Own Shares | GlaxoSmithKline PLC | RNS |
| 12/08/13 | | 17:23:45 | 12 Aug 2013 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 12/08/13 | | 17:21:53 | 12 Aug 2013 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 12/08/13 | | 13:12:23 | 12 Aug 2013 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 09/08/13 | | 18:11:03 | 9 Aug 2013 | | | Transaction in Own Shares | GlaxoSmithKline PLC | RNS |
| 08/08/13 | | 18:11:53 | 8 Aug 2013 | | | Transaction in Own Shares | GlaxoSmithKline PLC | RNS |
| 07/08/13 | | 18:01:54 | 7 Aug 2013 | | | Transaction in Own Shares | GlaxoSmithKline PLC | RNS |
| 06/08/13 | | 18:06:50 | 6 Aug 2013 | | | Transaction in Own Shares | GlaxoSmithKline PLC | RNS |
| 06/08/13 | | 17:25:30 | 6 Aug 2013 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 05/08/13 | | 17:30:29 | 5 Aug 2013 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 05/08/13 | | 13:35:11 | 5 Aug 2013 | | | Publication of Prospectus | GlaxoSmithKline PLC | RNS |
| 02/08/13 | | 18:13:49 | 2 Aug 2013 | | | Transaction in Own Shares | GlaxoSmithKline PLC | RNS |
| 02/08/13 | | 16:05:47 | 2 Aug 2013 | | | Regulatory Update - Albiglutide | GlaxoSmithKline PLC | RNS |
| 01/08/13 | | 18:00:17 | 1 Aug 2013 | | | Transaction in Own Shares | GlaxoSmithKline PLC | RNS |
| 01/08/13 | | 15:13:05 | 1 Aug 2013 | | | Total Voting Rights | GlaxoSmithKline PLC | RNS |